Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi: Phio Pharmaceuticals (PHIO)
The financial EBITDA metric demonstrates profit dynamics, where the value of 0.00 serves as the current indicator. The Phio Pharmaceuticals (PHIO) business is not subject to market cycles or seasonality, maintaining resilience against macro shocks. High barriers to entry are ensured by INTASYL patents and strict FDA control. The foundation for success is rooted in breakthrough RNA self-delivery technology, which enables the effective blocking of genes associated with dangerous diseases.
Ringkesan rincian data analitis Phio Pharmaceuticals Corp. (PHIO)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- indikator kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Phio Pharmaceuticals|PHIO - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Phio Pharmaceuticals Corp|PHIO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Phio Pharmaceuticals|PHIO - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Phio Pharmaceuticals|Likuiditas darurat phiopharma.com
- statistik bathi lan rasio pasar:
PHIO - Penghasilan resik|Proyeksi bathi mangsa ngarep Phio Pharmaceuticals|PHIO - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Phio Pharmaceuticals Corp|PHIO - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Phio Pharmaceuticals|PHIO - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Phio Pharmaceuticals|PHIO - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan phiopharma.com|PHIO - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Phio Pharmaceuticals
Ringkesan analitik perusahaan:PHIO (Phio Pharmaceuticals)
The development of the INTASYL oncology platform requires colossal expenditures for Phio Pharmaceuticals (PHIO), making the company's absolute operating profit in cash terms a critical marker of resource management efficiency. This indicator aggregates cash flow from core operations before interest and taxes, allowing investors to assess the business's real solvency and the pace of innovation scaling between quarterly reports.
Karo sapa Phio Pharmaceuticals saingan
Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TEM|QGEN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi IONS|RGEN: Bathi operasional EBITDA|Avidity Biosciences Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|CRSP (CRISPR Therapeutics Corp) - Bathi operasional EBITDA|Bathi operasional EBITDA GeneDx Corp|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Ultragenyx Pharmaceutical (RARE)|BEAM (beamtx.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sarepta SRPT|TWST - Bathi operasional sadurunge ngurangi amortisasi|10x Genomics Corp - Bathi operasional EBITDA|NTLA - Bathi operasional EBITDA|STOK: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi biolifesolutions.com|WVE (Wave Life Sciences Ltd.) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Maze Therapeutics, Inc. MAZE|Bathi operasional sadurunge ngurangi amortisasi SION (Sionna Pharma)|Bathi operasional EBITDA Prime Medicine Bio (PRME)|Taysha Gene Therapies - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi QURE (uniqure.com)|MeiraGTx - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi REGENXBIO Inc RGNX|SLDB: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Ocugen Pharma|PACB (Pacific Biosciences) - Bathi operasional EBITDA|Bathi operasional EBITDA benitec.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Design Therapeutics, Inc. (DSGN)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi RCKT (Rocket Pharma)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi 4D Molecular Therapeutics Inc FDMT|Pendapatan operasional sadurunge ngurangi amortisasi Lexeo Therapeutics Inc. (LXEO)|KRRO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi EDIT|SLN: Bathi operasional EBITDA|ProQR Therapeutics - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|CDXS (Codexis Inc) - Bathi operasional EBITDA|Sangamo BioSciences (SGMO) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Nautilus Biotechnology (NAUT)|MGX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi operasional EBITDA DTIL (Precision BioSciences, Inc.)|GBIO: Bathi operasional sadurunge amortisasi|BOLD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|XCUR (Exicure, Inc.) - Bathi operasional sadurunge amortisasi|IMNN: Bathi operasional EBITDA|Mustang Bio (MBIO) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TransCode Therapeutics Inc.|Bionano - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA APDN|BLUE (bluebird bio, Inc) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA IPA (ImmunoPrecise Antibodies Ltd.)|Pendapatan operasional sadurunge ngurangi amortisasi omegatherapeutics.com (OMGA)|OMIC - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Regulus Therapeutics, Inc.|SYRS (Syros) - Bathi operasional sadurunge ngurangi amortisasi|Telesis Bio, Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TRACON Pharmaceuticals|unitybiotechnology.com - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi
